Game

NYSE CONTENT ADVISORY: PRE-MARKET UPDATE FOR FEBRUARY 24TH

NEW YORK,Feb. 24,2025-- The New York Stock Exchange (NYSE) is proud to offer a daily pre-market update directly from the NYSE Trading Floor. Access today\'s NYSE Pre-market update for market insight

02-25 New York Stock Exchange

Amcor to present at the Bank of America 2025 Global Agriculture and Materials Conference on February 26, 2025

­ZURICH,Feb. 24,2025-- Amcor (NYSE: AMCR,ASX:AMC),a global leader in developing and producing responsible packaging solutions will present at the at the Bank of America 2025 Global Agriculture and

02-25 Amcor

Starburst Closes Record FY25, Fueled by Rising AI Demand and Growing Enterprise Momentum

BOSTON,Feb. 20,2025--Starburst,the data platform for apps and AI,announced a record FY25 close,driven by strong demand from enterprise customers:

02-21

FIRST AND ONLY TREATMENT FOR CHRONIC HYPOPARATHYROIDISM APPROVED IN AUSTRALIA

YORVIPATH® (palopegteriparatide) is now registered by the Therapeutic Goods Administration (TGA) for the treatment of chronic hypoparathyroidism in adults1

02-21

Milken Institute to Present the Second Global Investors' Symposium in Hong Kong, Charting a Path for Connecting Global Markets

The flagship investment-focused Symposium builds on the success of the inaugural event and will prioritize connecting global investors,chief executives,business leaders,and policymakers around the wo

02-21 Milken Institute

Youdao Reports Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results

HANGZHOU,China,Feb. 20,2025-- Youdao,Inc. ("Youdao" or the "Company") (NYSE: DAO),an intelligent learning company with industry-leading technology in China,today announced its unau

02-21 Youdao, Inc.

Ampace Obtains Amazon Climate Pledge Friendly Certification

Ampace Obtains Amazon Climate Pledge Friendly Certification,Pioneering Zero-Carbon Energy Solutions with Green Tech

02-21 Ampace Technology

Akeso Enrolled First Patient in The Phase III Clinical Trial of Ivonescimab in Combination with Chemotherapy for First-Line Treatment of Triple-Negative Breast Cancer

HONG KONG,Feb. 21,2025-- Akeso,Inc. (9926.HK) ("Akeso" or the "Company") today announced the company has successfully enrolled the first patient in itsmulticenter,randomized,double

02-21 Akeso, Inc.

Bestqool Unveils Four-Wavelength Pro Series and Second-Gen Mobile Stand at Original Price

NEW YORK,Feb. 21,2025-- In a recent announcement,Bestqool is upgrading both the Pro100 and Pro200 to the four-wavelength configuration (630 nm,660 nm,850 nm,940 nm) as the Pro 300,without increasing

02-21 Bestqool

Rizhao embraces maritime development for future growth

RIZHAO,China,Feb. 19,2025-- A news report from chinadaily.com.cn: Rizhao,located in East China\'s Shandong province,is advancing the high-quality integration of its port,industry,and city,charting a c

02-20 chinadaily.com.cn